Marta Sobas

Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice

Ralph Tiedt, Hui Hao-Shen, Marta Sobas et al. · Blood · 2007 · 434 citations · Full text

Veterinary Medicine, Genetics, Molecular Genetics +12

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

Tiziano Barbui, Alessandro M. Vannucchi, Alberto Álvarez‐Larrán et al. · Leukemia · 2021 · 82 citations · Full text

Medicine, Hematology, Pharmacology +15

Concordance of assays designed for the quantification of JAK2V617F: a multicenter study

Éric Lippert, François Girodon, E. Hammond et al. · Haematologica · 2008 · 77 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study

Sabine Käyser, Ramy Rahmé, David Martínez‐Cuadrón et al. · Leukemia · 2020 · 50 citations · Full text

Medicine, Oncology, Pharmacology +13

Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs

Marta Sobas, Jean‐Jacques Kiladjian, Yan Beauverd et al. · Blood Advances · 2022 · 43 citations · Full text

Medicine, Hematology, Pediatrics +15